BMJ 2003;327 (11 October), doi:10.1136/bmj.327.7419.0
Compliance therapy does not improve drug adherence in schizophrenia
Pragmatic talking therapy designed to improve adherence to drug treatment in schizophrenia patients fails. O'Donnell and colleagues (p 834) randomised 56 schizophrenia patients either to compliance therapy, a cognitive behavioural based motivational and psychoeducational intervention, or to non specific counselling. They found that adherence at one year was no better among patients in the intervention group, nor did patients' symptoms or quality of life improve. They also found that patients' attitudes to treatment strongly predicted later adherence.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
StumbleUpon 
Technorati What's this?
Relevant Article
- Compliance therapy: a randomised controlled trial in schizophrenia
- Colin O'Donnell, Gary Donohoe, Louise Sharkey, Nicholas Owens, Maria Migone, Raewynn Harries, Anthony Kinsella, Conall Larkin, and Eadbhard O'Callaghan
BMJ 2003 327: 834.[Abstract] [Full Text] [PDF]
This Article
- Respond to this article
- Alert me when this article is cited
- Alert me when responses are posted
- Alert me when a correction is posted
Services
- Email this article to a friend
- Find similar articles in BMJ
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
Related Content
Bookmark with
What's new
Latest blogs
Find BMJ on:
Services
Tools
Online poll
Resources
Rapid responses for this article
There are no rapid responses for this article. Print issues
